A carregar...

Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor ß levels in rheumatoid arthritis

Methods: Plasma levels of TGFß1 and TGFß2 were determined in 26 patients with RA during six months of etanercept treatment and compared with disease activity and laboratory parameters, including matrix metalloproteinase-3 (MMP-3) and interleukin 6 (IL6). Results: Before treatment all patients had ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Drynda, S, Kuhne, C, Kekow, J
Formato: Artigo
Idioma:Inglês
Publicado em: 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754023/
https://ncbi.nlm.nih.gov/pubmed/11830433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.61.3.254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!